Literature DB >> 19878070

Effects of resin or charcoal treatment on fetal bovine serum and bovine calf serum.

Zhimin Cao1, Clint West, Carol S Norton-Wenzel, Robert Rej, Faith B Davis, Paul J Davis, Robert Rej.   

Abstract

INTRODUCTION: Charcoal- or resin-stripping of fetal bovine serum (FBS) or bovine calf serum (BCS) intended for supplementation of cell culture media is widely practiced to remove a variety of endogenous compounds, including steroid, peptide, and thyroid hormones. The possibility that stripping removes other biologically relevant factors from serum may not be appreciated.
METHODS: In this report, standardized clinical laboratory testing methods were used to assess the effects of resin- and charcoal-stripping on content in FBS and BCS of more than 25 analytes in the sera. RESULTS AND
CONCLUSION: In addition to hormones, the serum constituents affected by stripping are certain vitamins, electrolytes, enzyme activities, and metabolites.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19878070     DOI: 10.3109/07435800903204082

Source DB:  PubMed          Journal:  Endocr Res        ISSN: 0743-5800            Impact factor:   1.720


  27 in total

1.  17β-Estradiol inhibits HIV-1 by inducing a complex formation between β-catenin and estrogen receptor α on the HIV promoter to suppress HIV transcription.

Authors:  Erika L Szotek; Srinivas D Narasipura; Lena Al-Harthi
Journal:  Virology       Date:  2013-06-12       Impact factor: 3.616

2.  LPS and palmitate synergistically stimulate sphingosine kinase 1 and increase sphingosine 1 phosphate in RAW264.7 macrophages.

Authors:  Junfei Jin; Zhongyang Lu; Yanchun Li; Ji Hyun Ru; Maria F Lopes-Virella; Yan Huang
Journal:  J Leukoc Biol       Date:  2018-06-08       Impact factor: 4.962

Review 3.  Nongenomic signaling pathways of estrogen toxicity.

Authors:  Cheryl S Watson; Yow-Jiun Jeng; Mikhail Y Kochukov
Journal:  Toxicol Sci       Date:  2009-12-02       Impact factor: 4.849

4.  Effects of gender-specific adult bovine serum on myogenic satellite cell proliferation, differentiation and lipid accumulation.

Authors:  Dong-Mok Lee; Prati Bajracharya; Eun Ju Lee; Ji-Eun Kim; Hyung-Jeong Lee; Taehoon Chun; Jiehoe Kim; Kyung Hyun Cho; Jongsoo Chang; Seongkoo Hong; Inho Choi
Journal:  In Vitro Cell Dev Biol Anim       Date:  2011-05-26       Impact factor: 2.416

5.  SILEC: a protocol for generating and using isotopically labeled coenzyme A mass spectrometry standards.

Authors:  Sankha S Basu; Ian A Blair
Journal:  Nat Protoc       Date:  2011-12-08       Impact factor: 13.491

6.  A synthetic lethal screen identifies the Vitamin D receptor as a novel gemcitabine sensitizer in pancreatic cancer cells.

Authors:  V Bhattacharjee; Y Zhou; T J Yen
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 7.  Molecular aspects of thyroid hormone actions.

Authors:  Sheue-Yann Cheng; Jack L Leonard; Paul J Davis
Journal:  Endocr Rev       Date:  2010-01-05       Impact factor: 19.871

8.  Serum-free complete medium, an alternative medium to mimic androgen deprivation in human prostate cancer cell line models.

Authors:  Michael V Fiandalo; John H Wilton; Krystin M Mantione; Carol Wrzosek; Kristopher M Attwood; Yue Wu; James L Mohler
Journal:  Prostate       Date:  2017-12-01       Impact factor: 4.104

9.  American Thyroid Association Guide to investigating thyroid hormone economy and action in rodent and cell models.

Authors:  Antonio C Bianco; Grant Anderson; Douglas Forrest; Valerie Anne Galton; Balázs Gereben; Brian W Kim; Peter A Kopp; Xiao Hui Liao; Maria Jesus Obregon; Robin P Peeters; Samuel Refetoff; David S Sharlin; Warner S Simonides; Roy E Weiss; Graham R Williams
Journal:  Thyroid       Date:  2013-12-12       Impact factor: 6.568

10.  Elevated LIM kinase 1 in nonmetastatic prostate cancer reflects its role in facilitating androgen receptor nuclear translocation.

Authors:  Katerina Mardilovich; Mads Gabrielsen; Lynn McGarry; Clare Orange; Rachana Patel; Emma Shanks; Joanne Edwards; Michael F Olson
Journal:  Mol Cancer Ther       Date:  2014-10-24       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.